A detailed history of Main Management ETF Advisors, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Main Management ETF Advisors, LLC holds 21,360 shares of SWTX stock, worth $1.03 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
21,360
Previous 23,280 8.25%
Holding current value
$1.03 Million
Previous $746,000 3.49%
% of portfolio
0.03%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$28.61 - $42.55 $54,931 - $81,696
-1,920 Reduced 8.25%
21,360 $772,000
Q3 2024

Nov 15, 2024

BUY
$32.04 - $42.76 $745,891 - $995,452
23,280 New
23,280 $746,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $3.02B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Main Management ETF Advisors, LLC Portfolio

Follow Main Management ETF Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Management ETF Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Management ETF Advisors, LLC with notifications on news.